Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.
OBJECTIVE
Although infection with hepatitis C virus (HCV) affects 32 million individuals from Southeast Asia, little is known about the mode of HCV acquisition and the epidemiology of chronic hepatitis C (CHC) in these individuals. Our goal was to examine risk factors for HCV acquisition, prevalence, and clinical characteristics of HCV genotype 6 compared with genotypes 1 and 2/3 in Southeast Asian (SEA) patients.


METHODS
We performed a cross-sectional study of 308 consecutive SEA Americans with CHC evaluated by five gastroenterologists from January 2000 to December 2008 at two community clinics in northern California via medical record review, using a case report form.


RESULTS
A significant proportion of patients (41%) could not recall any specific risk factors for HCV acquisition. The most commonly reported risk factor in patients who reported at least one risk factor was history of surgeries (34%), followed by blood transfusion (25%) and acupuncture (13%). Among patients with core sequence testing for HCV genotype (n = 181), the most common HCV genotypes were genotype 1 (42%) and genotype 6 (41%), followed by genotype 2/3 (17%). There were no major differences in the clinical and virological characteristics between the different genotype groups (1 vs. 2/3 vs. 6).


CONCLUSIONS
HCV genotype 6 is as common as genotype 1 in SEAs. Commonly known risk factors for HCV acquisition were not readily identifiable in a large proportion of SEA Americans (41%) and may not be useful in identifying at-risk individuals for HCV screening in this population.
Nguyen
Nghia H
NH
Vutien
Philip
P
Trinh
Huy N
HN
Garcia
Ruel T
RT
Nguyen
Long H
LH
Nguyen
Huy A
HA
Nguyen
Khanh K
KK
Nguyen
Mindie H
MH
J Gastroenterol. 2009;44 Suppl 19:102-7
19148802
Ann Intern Med. 2004 Nov 2;141(9):715-7
15520428
J Infect Dis. 2003 Apr 1;187(7):1071-4
12660921
Wkly Epidemiol Rec. 1999 Dec 10;74(49):425-7
10645164
Hepatology. 2002 Nov;36(5):1259-65
12395338
Hepatology. 1995 Oct;22(4 Pt 1):1050-6
7557850
Ann Intern Med. 2007 Nov 20;147(10):677-84
18025443
Rev Epidemiol Sante Publique. 2007 Apr;55(2):107-12
17442516
J Clin Gastroenterol. 2002 Sep;35(3):266-9
12192205
Hepatology. 1997 Sep;26(3 Suppl 1):122S-127S
9305676
MMWR Recomm Rep. 1998 Oct 16;47(RR-19):1-39
9790221
Am J Gastroenterol. 2006 Dec;101(12):2737-43
17227521
Am J Gastroenterol. 2008 Jan;103(1):131-7
17894850
Ann Intern Med. 2006 May 16;144(10):705-14
16702586
J Clin Microbiol. 1996 Sep;34(9):2259-66
8862595
Hepatology. 2002 Nov;36(5 Suppl 1):S93-8
12407581
J Infect Dis. 2008 Sep 15;198(6):808-12
18657036
Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16
15508102
Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8239-43
8058787
J Gastroenterol Hepatol. 2004 Jul;19(7):792-8
15209627
N Engl J Med. 1998 Nov 19;339(21):1485-92
9819446
Hepatol Res. 2007 Sep;37 Suppl 2:S101-5
17877468
Hepatology. 2002 Nov;36(5 Suppl 1):S74-83
12407579
Semin Liver Dis. 1999;19(3):271-85
10518307
Am J Gastroenterol. 2008 May;103(5):1131-5
18477343
Clin Liver Dis. 2005 Aug;9(3):411-26, vi
16023974
Zhonghua Yi Xue Za Zhi (Taipei). 1996 Oct;58(4):275-80
8994333
Hepatol Int. 2007 Sep;1(3):387-93
19669334
Lancet. 1998 Oct 31;352(9138):1426-32
9807989